Prediction of tumor heterogeneity in localized prostate cancer

H Huland, M Graefen, A Haese, PG Hammerer, J Palisaar, U Pichlmeier, RP Henke, A Erbersdobler, E Huland, Hans Lilja

Research output: Contribution to journalArticlepeer-review

7 Citations (SciVal)


The clinical T1-T2 prostatic carcinoma is a heterogeneous tumor in respect to pathologic stage and outcome. Tumor heterogeneity can be fairly good predicted by the use of classification and regression tree analysis with preoperative parameters, especially a quantitative analysis of Gleason grade 4-5 cancer in six systematic biopsies and a determination of preoperative prostate-specific antigen levels, to predict lymph node status, capsular penetration, and outcome.
Original languageEnglish
Pages (from-to)213
JournalUrologic Clinics of North America
Issue number1
Publication statusPublished - 2002

Subject classification (UKÄ)

  • Medicinal Chemistry


Dive into the research topics of 'Prediction of tumor heterogeneity in localized prostate cancer'. Together they form a unique fingerprint.

Cite this